antimalaria
drug
chloroquin
well
known
autophagi
inhibitor
chloroquin
also
use
antiinflammatori
drug
treat
inflammatori
diseas
hypothes
chloroquin
could
dual
effect
liver
ischemiareperfus
ir
injuri
chloroquin
one
hand
could
protect
liver
ir
injuri
via
inhibit
inflammatori
respons
hand
could
aggrav
liver
ir
injuri
inhibit
autophagi
rat
n
per
group
pretreat
chloroquin
mgkg
ip
h
warm
ischemia
continu
subject
daili
chloroquin
inject
day
rat
kill
h
reperfus
earli
phase
ie
h
reperfus
chloroquin
treatment
amelior
liver
ir
injuri
indic
lower
serum
aminotransferas
level
lower
hepat
inflammatori
cytokin
fewer
histopatholog
chang
contrast
chloroquin
worsen
liver
injuri
late
phase
reperfus
ie
h
reperfus
mechan
protect
action
chloroquin
appear
involv
abil
modul
mitogenactiv
protein
kinas
activ
reduc
highmobl
group
box
releas
inflammatori
cytokin
product
wherea
chloroquin
worsen
liver
injuri
via
inhibit
autophagi
induct
hepat
apoptosi
late
phase
conclus
chloroquin
prevent
ischem
liver
damag
earli
phase
aggrav
liver
damag
late
phase
liver
ir
injuri
dual
role
chloroquin
consid
use
chloroquin
inhibitor
inflamm
autophagi
ir
injuri
ischemiareperfus
ir
injuri
occur
procedur
liver
transplant
liver
resect
trauma
surgic
procedur
liver
transient
depriv
oxygen
subsequ
reoxygen
injuri
liver
caus
ir
shown
associ
increas
rate
acut
liver
failuregraft
reject
chronic
liver
dysfunct
liver
transplant
mechan
liver
damag
ir
studi
extens
signal
event
contribut
cellular
tissu
damag
divers
complex
consist
complex
interact
multipl
inflammatori
pathway
proinflammatori
cytokin
highmobl
group
box
tumor
necrosi
factor
tnf
interleukin
il
known
increas
serum
liver
tissu
reperfus
pivot
role
pathophysiolog
hepat
ir
injuri
chloroquin
wellknown
antimalaria
drug
also
frequent
use
treatment
inflammatori
diseas
includ
rheumatoid
arthriti
system
lupu
erythematod
suggest
therapeut
effect
chloroquin
diseas
relat
immunoregulatori
potenc
recent
evid
shown
chloroquin
inhibit
proinflammatori
cytokin
product
macrophag
monocyt
stimul
lipopolysaccharid
lp
cpg
oligonucleotid
cpg
odn
vivo
chloroquin
protect
mice
lethal
dose
lp
cpg
odn
decreas
proinflammatori
cytokin
releas
furthermor
chloroquin
protect
mice
sepsisinduc
acut
kidney
injuri
decreas
serum
inflammatori
cytokin
level
prompt
result
hypothes
chloroquin
could
also
possess
antiinflammatori
abil
protect
reduc
hepat
ir
injuri
character
inflammatori
injuri
contrast
abil
inhibit
inflamm
grow
bodi
evid
suggest
chloroquin
administr
worsen
ir
injuri
via
inhibit
autophagi
chloroquin
also
induc
apoptosi
vitro
vivo
via
inhibit
autophag
protein
degrad
autophagi
involv
variou
physiolog
process
liver
diseas
cancer
age
also
ir
injuri
hepat
ir
injuri
autophagi
induc
liver
induct
autophagi
associ
prosurviv
activ
allow
cell
cope
nutrient
starvat
anoxia
induct
autophagi
associ
attenu
ir
injuri
previou
result
led
us
hypothes
chloroquin
could
also
worsen
liver
injuri
via
inhibit
hepat
autophagi
induct
hepat
apoptosi
ir
injuri
given
inhibit
inflamm
reduc
hepat
ir
injuri
inhibit
autophagi
may
worsen
hepat
ir
injuri
hypothes
chloroquin
antiinflammatori
autophagi
inhibitori
drug
could
dual
effect
liver
ir
injuri
chloroquin
one
hand
could
protect
liver
ir
injuri
via
inhibit
inflammatori
respons
hand
could
aggrav
liver
ir
injuri
inhibit
autophagi
induct
apoptosi
therefor
aim
studi
investig
precondit
effect
chloroquin
administr
rat
hepat
ir
injuri
chloroquin
reduc
liver
injuri
earli
reperfus
phase
worsen
liver
injuri
late
reperfus
phase
hepat
ischem
injuri
determin
whether
chloroquin
treatment
could
affect
liver
ir
injuri
chloroquin
administr
rat
h
warm
ischemia
follow
daili
inject
day
liver
warm
ir
result
signific
increas
serum
level
alanin
transaminas
alt
aspart
aminotransferas
ast
shown
figur
follow
min
warm
ischemia
chloroquin
treatment
decreas
ir
injuri
h
indic
lower
liver
enzym
howev
serum
level
alt
ast
much
higher
follow
reperfus
compar
figur
chloroquin
treatment
prevent
liver
ir
injuri
earli
phase
worsen
late
phase
follow
ir
injuri
rat
pretreat
either
chloroquin
mgkg
vehicl
salin
h
warm
ischemia
follow
addit
chloroquin
inject
h
reperfus
follow
min
min
b
warm
ischemia
liver
injuri
assess
variou
time
point
follow
reperfus
determin
serum
ast
alt
level
data
shown
mean
sd
compar
vehicletr
ir
group
c
routin
histopatholog
perform
formalinfix
liver
section
obtain
rat
undergon
min
ischemia
follow
reperfus
respect
origin
magnif
repres
imag
six
rat
per
group
select
vehicleinject
rat
confirm
dual
effect
chloroquin
liver
ir
injuri
addit
rat
subject
min
warm
ir
chloroquin
treatment
caus
similar
dual
effect
term
liver
injuri
rat
subject
prolong
warm
ischem
insult
figur
liver
histolog
confirm
find
regard
liver
injuri
describ
moder
hepatocellular
necrosi
cytoplasm
vacuol
hepatocyt
sinusoid
dilat
observ
h
reperfus
vehicletr
rat
contrast
minor
hepatocellular
necrosi
slight
sinusoid
dilat
observ
chloroquin
treatment
group
howev
chloroquinetr
rat
show
sever
cytoplasm
vacuol
hepatocellular
necrosi
h
reperfus
compar
vehicletr
rat
figur
tabl
chloroquin
treatment
decreas
hepat
inflammatori
cytokin
gene
express
express
hepat
mrna
tnfa
induc
nitric
oxid
synthas
ino
measur
quantit
pcr
shown
figur
follow
warm
ischemia
hepat
tnfa
ino
express
level
increas
h
vehicl
treatment
group
chloroquin
treatment
group
compar
shamoper
control
howev
chloroquinetr
rat
exhibit
minim
increas
hepat
tnfa
ino
mrna
level
compar
vehicleinject
anim
account
decreas
h
reperfus
respect
chloroquin
treatment
decreas
releas
earli
phase
cytokin
releas
hepat
ischemia
earli
reperfus
phase
shown
figur
nuclear
stain
hepatocyt
substanti
loss
vehicleinject
control
rat
earli
h
reperfus
contrast
pretreat
chloroquin
larg
prevent
loss
nuclear
stain
assess
extracellular
releas
warm
liver
ir
injuri
serum
concentr
quantifi
use
enzymelink
immunosorb
assay
elisa
shown
figur
warm
ir
injuri
caus
releas
vehicletr
rat
chloroquinetr
rat
serum
level
highest
h
reperfus
ngml
gradual
decreas
thereaft
h
versu
normal
control
contrast
chloroquinetr
rat
show
lower
serum
level
compar
vehicletr
rat
serum
level
drastic
decreas
follow
reperfus
ngml
h
respect
chloroquin
treatment
modul
liver
irinduc
inflammatori
signal
pathway
among
proxim
event
ir
activ
mitogenactiv
protein
map
kinas
determin
chloroquin
pretreat
influenc
map
kinas
activ
assess
phosphoryl
extracellular
signalregul
kinas
erk
cjun
ntermin
kinas
jnk
shown
figur
ir
phosphoryl
jnk
increas
vehicletr
rat
contrast
phosphorl
jnk
decreas
wherea
phosphoryl
increas
chloroquineinject
rat
phosphoryl
erk
increas
h
decreas
h
recov
thereaft
dephosphoryl
partial
prevent
chloroquin
treatment
treatment
chloroquin
affect
total
cellular
level
jnk
erk
data
suggest
chloroquin
could
act
upstream
map
kinas
activ
chloroquin
treatment
decreas
autophagi
autophagi
highli
conserv
cellular
process
recycl
damag
longliv
protein
organel
grow
evid
show
chloroquin
decreas
autophagi
number
cell
type
determin
whether
chloroquin
could
inhibit
hepat
autophagi
follow
ir
western
blot
perform
microtubuleassoci
protein
light
chain
liver
obtain
rat
pretreat
either
chloroquin
vehicl
shown
figur
shamoper
rat
low
level
follow
min
warm
ischemia
protein
increas
h
reperfus
decreas
express
contrast
chloroquin
treatment
increas
significantli
express
respons
liver
ir
data
indic
chloroquin
inhibit
hepat
postischem
autophagi
report
chloroquineinduc
apoptosi
vitro
vivo
via
inhibit
autophag
protein
degrad
prompt
find
focus
studi
express
apoptot
protein
shown
figur
cleavag
increas
respons
liver
ir
contrast
chloroquin
treatment
increas
liver
irinduc
cleavag
furthermor
chloroquinetr
rat
demonstr
significantli
higher
hepat
cleav
level
compar
vehicleinject
rat
data
indic
chloroquin
treatment
could
increas
irinduc
apoptosi
induct
apoptosi
late
phase
reperfus
associ
increas
hepat
injuri
indic
elev
liver
enzym
sever
histopatholog
chang
antimalaria
drug
chloroquin
well
known
autophagi
inhibitor
compound
also
known
drug
dual
role
chloroquin
liver
ir
injuri
h
fang
et
al
antiinflammatori
properti
howev
report
recent
chloroquin
treatment
aggrav
ir
injuri
character
inflammatori
injuri
reason
investig
effect
chloroquin
liver
ir
injuri
underli
mechan
detail
best
knowledg
first
report
show
chloroquin
dual
effect
liver
ir
injuri
follow
min
warm
ischemia
chloroquin
treatment
reduc
liver
injuri
h
aggrav
liver
injuri
h
reperfus
earli
phase
ie
h
reperfus
protect
effect
chloroquin
treatment
associ
modul
map
kinas
activ
inhibit
releas
reduct
inflammatori
cytokin
product
contrast
late
phase
reperfus
ie
h
reperfus
chloroquin
treatment
associ
aggrav
liver
injuri
inhibit
autophagi
induct
apoptosi
studi
mechan
protect
chloroquin
treatment
earli
phase
reperfus
investig
effect
proinflammatori
cytokin
express
chloroquin
extens
use
treatment
chronic
inflammatori
diseas
hypothes
chloroquin
may
also
possess
antiinflammatori
abil
liver
ir
injuri
also
regard
inflammatori
injuri
studi
effect
chloroquin
proinflammatori
cytokin
gene
express
rat
precondit
chloroquin
ischem
insult
demonstr
follow
min
warm
ischemia
chloroquin
treatment
reduc
tnfa
ino
gene
express
h
reperfus
cytokin
known
pivot
role
pathophysiolog
hepat
ir
injuri
recent
studi
suggest
extracellular
releas
damag
liver
cell
caus
proinflammatori
intrahepat
microenviron
postischem
liver
therefor
investig
whether
chloroquin
treatment
could
modul
releas
consist
find
previou
studi
group
mainli
present
nucleu
hepatocyt
normal
liver
transloc
nucleu
cytoplasm
liver
ir
injuri
chloroquin
treatment
reduc
hepat
transloc
serum
level
earli
phase
releas
induc
synthesi
proinflammatori
cytokin
caus
liver
damag
liver
ir
injuri
treatment
neutral
antibodi
significantli
decreas
liver
ir
injuri
data
suggest
inhibit
hepat
transloc
subsequ
releas
involv
hepatoprotect
effect
chloroquin
earli
phase
reperfus
gain
insight
mechan
induc
protect
effect
chloroquin
influenc
activ
mapk
signal
pathway
studi
recent
demonstr
activ
map
kinas
pathway
major
role
liver
ir
injuri
chloroquin
inhibit
signal
pathway
monocyt
macrophag
epitheli
cell
chloroquin
inhibit
activ
erk
lead
suppress
cytokin
product
caus
cpg
dna
studi
protect
hepatocyt
convers
jnk
activ
deleteri
even
hypox
hepatocyt
via
mitochondri
permeabl
transit
mpt
inhibit
jnk
activ
decreas
necrosi
apoptosi
liver
ir
taken
togeth
data
suggest
modul
map
kinas
activ
also
involv
hepat
protect
effect
chloroquin
elucid
molecular
basi
chloroquinemedi
injuri
late
phase
liver
ir
injuri
investig
effect
activ
autophagi
autophagi
highli
conserv
regul
cellular
process
cytoplasm
constitu
includ
organel
broken
recycl
lysosom
degrad
pathway
execut
autophagi
involv
set
evolutionarili
conserv
autophagyrel
gene
atg
protein
requir
induct
autpophagi
gener
matur
recycl
autophagosom
homologu
yeast
exist
two
form
proteolyt
deriv
synthesi
cleav
expos
ctermin
glycin
residu
repres
cytosol
form
subsequ
conjug
phosphatidylethanolamin
becom
local
isol
membran
autophag
membran
amount
correl
number
autophagosom
thu
use
estim
autophag
activ
select
incorpor
autophagosom
via
direct
bind
identifi
one
specif
substrat
degrad
autophagylysosom
pathway
thu
total
cellular
express
level
invers
correl
autophag
activ
chloroquin
recent
use
inhibit
autophagi
vivo
without
notic
side
effect
chloroquin
rais
lysosom
ph
lead
inhibit
lysosomeautophagosom
fusion
lysosom
protein
degrad
studi
chloroquin
block
autophag
flux
shown
accumul
aggrav
liver
ir
injuri
reperfus
impair
autophagi
lead
develop
mpt
hypox
hepatocyt
onset
mpt
lead
phdepend
necrot
cell
death
well
apoptot
cell
death
releas
proapoptot
protein
factor
normal
sequest
mitochondri
intermembran
space
inde
induct
autophagi
associ
attenu
ir
injuri
liver
demonstr
recent
treatment
chloroquin
significantli
decreas
autophagi
worsen
liver
injuri
conclud
decreas
autophagi
account
part
hepat
harm
effect
chloroquin
late
phase
reperfus
apoptot
cell
death
promin
role
evolut
organ
damag
follow
liver
ir
shown
inhibit
autophagi
trigger
apoptosi
apoptosi
defin
suicid
cell
death
particular
morpholog
involv
nuclear
chromatin
condens
trigger
activ
either
extrins
death
receptormedi
intrins
mitochondrialassoci
death
pathway
recent
studi
suggest
possibl
molecular
mechan
crosstalk
autophagi
apoptosi
famili
protein
wellcharacter
apoptosi
regul
recent
becom
clear
reduc
beclin
autophagi
inhibit
format
beclin
complex
beclin
class
iii
activ
demonstr
inhibit
autophagi
chloroquin
prevent
fusion
autophagosom
lysosom
via
disrupt
ph
acid
vesicl
thu
increas
cellular
burden
autophagosom
shown
preced
possibl
induc
baxand
mitochondrialdepend
apoptosi
previou
result
led
us
investig
whether
chloroquin
could
also
increas
hepat
apoptosi
ir
injuri
result
show
chloroquin
treatment
increas
apoptot
cell
death
indic
increas
irinduc
caspas
protein
cleavag
togeth
data
suggest
chloroquinemedi
hepat
harm
effect
may
involv
induct
apoptosi
summari
demonstr
chloroquin
could
prevent
ischem
liver
damag
earli
phase
aggrav
liver
damag
late
phase
liver
ir
injuri
mechan
protect
action
chloroquin
earli
phase
seem
relat
abil
decreas
inflammatori
cytokin
releas
alter
irinduc
map
kinas
activ
harm
side
effect
chloroquin
late
phase
appear
involv
abil
induc
apoptosi
inhibit
autophagi
data
suggest
dual
role
chloroquin
consid
use
chloroquin
inhibitor
inflamm
autophagi
ir
injuri
experiment
design
experi
design
investig
effect
chloroquin
administr
rat
hepat
ir
injuri
rat
treat
chloroquin
mgkg
ip
h
warm
ischemia
continu
subject
daili
chloroquin
inject
day
rat
kill
h
reperfus
liver
injuri
inflammatori
cytokin
hepat
express
releas
map
kinas
activ
autophagi
apoptosi
analyz
anim
male
inbr
lewi
rat
purchas
charl
river
laboratori
sulzfeld
germani
weigh
within
g
use
studi
anim
hous
standard
anim
care
condit
free
access
water
rat
chow
ad
libitum
procedur
carri
accord
german
anim
welfar
legisl
partial
hepat
warm
ir
partial
hepat
warm
ir
model
perform
describ
previous
brief
open
abdomen
transvers
incis
interlobular
ligament
dissect
micro
vascular
clamp
use
interrupt
arteri
portal
venou
blood
suppli
left
later
median
liver
lobe
min
hepatocellular
damag
assay
assess
liver
damag
serum
ast
alt
measur
use
autom
chemic
analyz
bayer
advia
leverkusen
germani
histopatholog
liver
tissu
fix
buffer
formalin
embed
paraffin
section
mm
cut
stain
hematoxylineosin
histolog
evalu
perform
use
semiquantit
score
system
immunohistochemistri
immunohistochem
analysi
perform
describ
previous
briefli
deparaffin
rehydr
antigen
retriev
block
section
incub
antibodi
abcam
cambridg
uk
h
room
temperatur
detect
perform
use
powervis
goatantirabbitap
immunolog
duiven
netherland
use
fastr
abcam
substrat
gel
electrophoresi
western
blot
twenti
microgram
total
protein
separ
gel
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
transfer
polyvinyldifluorid
membran
ge
healthcar
buckinghamshir
uk
antibodi
phosphoryl
total
erk
enzymelink
immunosorb
assay
serum
determin
commerci
elisa
assay
shinotest
kanagawa
japan
procedur
perform
accord
instruct
manufactur
quantit
polymeras
chain
reaction
pcr
total
rna
extract
liver
tissu
use
rneasi
kit
qiagen
hilden
germani
reversetranscrib
complementari
dna
cdna
use
firststrand
cdna
synthesi
kit
invitrogen
carlsbad
ca
usa
primer
probe
statist
analysi
data
express
differ
group
evalu
signific
oneway
anova
analysi
test
perform
use
sigmastat
systatsoftwar
erkrath
germani
pvalu
consid
statist
signific
author
declar
conflict
interest
